This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dallas, TX (US) (2013)
- Austin, TX (US) (2020 - 2022)
Company Filing History:
Years Active: 2013-2022
Title: Xunde Xian: Innovator in Atherosclerosis Treatment
Introduction
Xunde Xian is a prominent inventor based in Austin, TX (US). He has made significant contributions to the field of medical research, particularly in the treatment of atherosclerosis. With a total of 3 patents, his work focuses on innovative methods to improve health outcomes for patients suffering from this condition.
Latest Patents
Xunde Xian's latest patents include groundbreaking inventions related to Reelin antibodies for the treatment of atherosclerosis. The first patent provides methods and compositions for treating atherosclerosis in a subject by utilizing therapeutic compounds to reduce Reelin in the circulation. This reduction leads to decreased adhesion of leukocytes to the vascular wall. The second patent reiterates similar methods and compositions aimed at reducing leukocyte adhesion, further emphasizing the importance of his research in this area.
Career Highlights
Xunde Xian is affiliated with the University of Texas System, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to transform treatment approaches for atherosclerosis, a condition that affects millions worldwide.
Collaborations
Xunde Xian collaborates with esteemed colleagues such as Joachim Herz and Yinyuan Ding. Their combined expertise enhances the research efforts and contributes to the advancement of medical science.
Conclusion
Xunde Xian's contributions to the field of atherosclerosis treatment through his innovative patents highlight his role as a leading inventor. His work not only showcases his dedication to medical research but also promises to improve the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile